tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Danaher (DHR) and Intuitive Surgical (ISRG)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIBResearch Report), Danaher (DHRResearch Report) and Intuitive Surgical (ISRGResearch Report).

Biogen (BIIB)

In a report issued on July 20, Cory Kasimov from J.P. Morgan maintained a Hold rating on Biogen, with a price target of $221.00. The company’s shares closed last Thursday at $214.06, close to its 52-week low of $187.16.

According to TipRanks.com, Kasimov is a 5-star analyst with an average return of 17.1% and a 55.0% success rate. Kasimov covers the Healthcare sector, focusing on stocks such as Cerevel Therapeutics Holdings, Ultragenyx Pharmaceutical, and BioMarin Pharmaceutical.

Currently, the analyst consensus on Biogen is a Moderate Buy with an average price target of $238.85, representing a 14.7% upside. In a report issued on July 12, Robert W. Baird also maintained a Hold rating on the stock with a $224.00 price target.

See the top stocks recommended by analysts >>

Danaher (DHR)

J.P. Morgan analyst Rachel Vatnsdal maintained a Buy rating on Danaher yesterday and set a price target of $350.00. The company’s shares closed last Thursday at $279.23.

According to TipRanks.com, Vatnsdal is a 4-star analyst with an average return of 25.8% and a 63.6% success rate. Vatnsdal covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, Twist Bioscience, and DENTSPLY SIRONA.

Currently, the analyst consensus on Danaher is a Strong Buy with an average price target of $308.38, which is a 12.1% upside from current levels. In a report issued on July 13, Barclays also maintained a Buy rating on the stock with a $290.00 price target.

Intuitive Surgical (ISRG)

In a report released today, Robbie Marcus from J.P. Morgan maintained a Buy rating on Intuitive Surgical, with a price target of $240.00. The company’s shares closed last Thursday at $224.75.

According to TipRanks.com, Marcus is a 4-star analyst with an average return of 8.2% and a 48.6% success rate. Marcus covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Integra Lifesciences, and Baxter International.

Currently, the analyst consensus on Intuitive Surgical is a Strong Buy with an average price target of $252.92, a 14.5% upside from current levels. In a report issued on July 13, Truist Financial also maintained a Buy rating on the stock with a $270.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BIIB:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More